Distinct binding modes shape exploitable asymmetries between echinocandin and triterpenoid resistance landscapes in Fks1
Echinocandins are the first-line treatment for invasive fungal infections and work by inhibiting the fungal {beta}-1,3-glucan synthase Fks1. Recently, a fi